Search results
Antibiotics, resistant bacteria found on ocean surface
Center for Infectious Disease Research and Policy· 1 day agoA total of 70% of marine bacteria were resistant to ofloxacin, 95% to clindamycin, 58% to clarithromycin, and 100% to novobiocin.
Antibiotics created from extinct species could fight infections
The Telegraph via Yahoo News· 4 days agoMolecules from extinct species like the woolly mammoth have been used in the fight to tackle ...
Rise of the Nanomachines
The New Yorker· 6 days agoAt the time, Santos was at the Centre for Interdisciplinary Research in Paris, studying genes that allow some bacteria to live longer than others. One...
AI Transforms Sepsis Care With Faster, More Effective Treatments
SciTechDaily· 4 days agoResearchers at Day Zero Diagnostics have developed Keynome gAST, an AI-driven genomic Antimicrobial...
Antibiotics wreak havoc on the gut. Can we kill the bad bugs and spare the good ones?
Los Angeles Times· 7 days agoInside every human is a thriving zoo of bacteria, fungi, viruses and other microscopic organisms...
Will we really die from minor scratches in the future? Q&A with antibiotic resistance expert
Medical Xpress· 1 day agoThe Conversation spoke to James P. O'Gara, a professor of microbiology, about the problem of...
Study details reduced Tamiflu susceptibility in H1N1 flu cases
Center for Infectious Disease Research and Policy· 5 days agoThe Netherlands had the most detections.
Experts warn of diphtheria-like illness that may spread between people, pets
UPI· 5 days agoResearchers believe that doctors now have to be on the lookout for C. ulceran, which has symptoms...
Destiny Pharma (LON:DEST) Given House Stock Rating at Shore Capital
ETF DAILY NEWS· 6 days agoShore Capital reaffirmed their house stock rating on shares of Destiny Pharma (LON:DEST – Free Report) in a research note issued to investors on Wednesday morning, MarketBeat Ratings reports ...
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Sees Large Growth in Short Interest
ETF DAILY NEWS· 6 days agoArmata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling ...